Last reviewed · How we verify
NCT05839925
Prevalence of Temporomandibular Joint Dysfunction in Patients With Ankylosing Spondylitis
trial testing Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Axis I and II in Ankylosing Spondylitis in 223 participants. Completed in 1 April 2023.
1 July 2022
Quick facts
| Lead sponsor | Istanbul Physical Medicine Rehabilitation Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 223 |
| Start date | 1 April 2022 |
| Primary completion | 1 July 2022 |
| Estimated completion | 1 April 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Axis I and II
Conditions studied
- Ankylosing Spondylitis — all drugs for Ankylosing Spondylitis →
Sponsor
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Who can join
Adults 18 to 75, any sex, with Ankylosing Spondylitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study included 113 patients diagnosed with ankylosing spondylitis and 110 healthy volunteers. Participants in both groups were evaluated using the 'Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)' diagnostic criteria. In addition, the relationship between temporomandibular joint dysfunction and disease activity was investigated in patients with ankylosing spondylitis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prevalence of temporomandibular joint dysfunction in patients with ankylosing spondylitis and comparison of the findings with healthy controls.
Ahısha BŞ, Kesiktaş FN. · · 2024 · PMID 39356963 · DOI 10.1590/1806-9282.20240807
Verify or expand the search:
- PubMed search for NCT05839925
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ankylosing Spondylitis
Currently open trials in the same condition.
- NCT07510789 — Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis · recruiting
- NCT07261644 — A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS) · Phase 3 · recruiting
- NCT07390929 — Clinical Trial Study on the Improved New Method of Acupotomy for AS · NA · recruiting
- NCT06905288 — Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. · recruiting
- NCT07166874 — The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis · NA · recruiting
Other Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials
Trials by the same sponsor.
- NCT07435935 — Bone Myoregulation Reflex and Postural Control in Vitamin D Deficiency · not yet recruiting
- NCT07308795 — The Ultrasonographic Evaluation of Abdominal Accessory Respiratory Muscle Thickness in Patients With Parkinson's Disease · recruiting
- NCT07367126 — Neuropathic Pain in Knee Osteoarthritis: Pain Severity and Functional Status · recruiting
- NCT07386145 — Frequency and Voluntary Contraction-Dependent Activation of Tonic Vibration Reflex and Bone Myoregulation Reflex · NA · completed
- NCT07408570 — FREQUENCY-DEPENDENT SOLEUS REFLEX MODULATION DURING WHOLE-BODY VIBRATION · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05839925 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Physical Medicine Rehabilitation Training and Research Hospital
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05839925.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing